Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine + CODOX-M/IVAC in Relapsed/Refractory T-lymphoblastic Lymphoma
NCT03558412Phase 4Unknown
- Start
- Jun 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of decitabine in T-cell lymphoblastic lymphoma (T-LBL). Status: unknown.
02
Drugs
decitabine
03
Conditions
T-cell lymphoblastic lymphoma (T-LBL)
Beyond the preview
Go deeper on NCT03558412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03558412.